A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2007
12/26/2007	CN100357270C D-proline derivative
12/26/2007	CN100356978C Novel exendin agonist formulations and methods administration thereof
12/26/2007	CN100356977C Regenerated human blood-platelet derivative growth factor gel
12/26/2007	CN100356953C Fat-reducing liver-protecting medicine and preparing method
12/26/2007	CN100356943C Medicinal composition for treating diabetes
12/26/2007	CN100356933C Blood fat reducing and liver protecting medicine prepared with cassia seed extract
12/26/2007	CN100356929C Medicinal composition for auxiliary treatment of asthenia healthy qi and its quality control method
12/26/2007	CN100356927C Cholesterol-lowering agents, secondary bile acid procuction inhibitors and foods and drinks
12/26/2007	CN100356917C Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes
12/26/2007	CN100356914C Method for preparing soybean isoflavone tablet
12/26/2007	CN100356913C R-bambuterol, its preparation and therapeutic uses
12/26/2007	CN100356871C Powder of amino acids and method for producing the same
12/25/2007	US7312344 Dimeric isoflavones
12/25/2007	US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders
12/25/2007	US7312321 Antibody to human enzymes of the metalloprotease family
12/25/2007	US7312304 Somatostatin agonists
12/25/2007	US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007	US7312219 Antidiabetic agents
12/25/2007	US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007	US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007	US7312193 Calcium phosphopeptide complexes
12/25/2007	US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
12/25/2007	US7312077 Insulin-secreting immortalized liver cell line modified by glucose sensitivity
12/25/2007	US7311919 Agents for treating osteoporosis and inhibiting osteoclast formation
12/25/2007	US7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
12/23/2007	CA2593501A1 Partially denatured whole soybean extracts and methods of use thereof
12/21/2007	WO2007146759A2 Novel mch receptor antagonists
12/21/2007	WO2007146758A2 Novel mch receptor antagonists
12/21/2007	WO2007146448A1 Pharmaceutical formulations of glp-1 derivatives
12/21/2007	WO2007146313A1 Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
12/21/2007	WO2007146126A2 Insulin composition
12/21/2007	WO2007146122A2 Tetrahydropyrido[3,4-d]pyrimidines and related analogues
12/21/2007	WO2007145519A1 Milk fever
12/21/2007	WO2007145356A1 α-GLUCOSIDASE INHIBITOR, INHIBITOR FOR BLOOD GLUCOSE LEVEL ELEVATION AND FUNCTIONAL FOOD CONTAINING TRICAFFEOYLALDARIC ACID AND METHOD FOR PRODUCING TRICAFFEOYLALDARIC ACID
12/21/2007	WO2007145253A1 NF-ϰB ACTIVATION INHIBITOR
12/21/2007	WO2007145239A1 Anti-fatigue agent containing amino acid composition
12/21/2007	WO2007145191A1 Coated tablet
12/21/2007	WO2007144571A1 Crystalline form of (trans-4- [ ( { 5- [ (3, 4 -di fluorophenyl) amino] -1,3, 4-oxadiazol-2-yl}carbonyl) amino] ph enyl } cyclohexyl) acetic acid
12/21/2007	WO2007144394A2 Pharmaceutical use of substituted piperidine carboxamides
12/21/2007	WO2007143951A1 COMPOUNDS WITH THE ACTIVITY OF PPARγ AGONIST AND APPLICATION THEREOF
12/21/2007	WO2007143824A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007	WO2007143823A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007	WO2007127688A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/21/2007	WO2007106469A3 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/21/2007	WO2007075555A3 Combination of an h3 antagonist/inverse agonist and an appetite suppressant
12/21/2007	WO2007016338A3 Use of chk2 kinase inhibitors for cancer treatment
12/21/2007	WO2007006790A3 Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist
12/21/2007	WO2006103342A8 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/21/2007	CA2655317A1 Ruminant feed supplement containing rice bran to avoid milk fever
12/21/2007	CA2655282A1 Pharmaceutical use of substituted piperidine carboxamides
12/21/2007	CA2654792A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007	CA2654098A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007	CA2653550A1 Crystalline form of (trans-4- [( { 5-[(3,4-difluorophenyl) amino]-1,3,4-oxadiazol-2-yl}carbonyl)amino]phenyl}cyclohexyl) acetic acid
12/21/2007	CA2653047A1 Type-2 diabetes combination wafer
12/21/2007	CA2652524A1 Novel mch receptor antagonists
12/21/2007	CA2652385A1 Novel mch receptor antagonists
12/21/2007	CA2646980A1 Compositions comprising porphyra and methods of making and using thereof
12/21/2007	CA2550753A1 Liquid vitamin and supplement formulations
12/20/2007	US20070294107 Uses Of Endopeptidases In Treatment Of Disease
12/20/2007	US20070293577 topical cosmetics such as Hydroxycitric acid-2-palmitate sodium salt, possessing body firming and slimming effects
12/20/2007	US20070293572 Anti-Fatigue Composition
12/20/2007	US20070293566 Combinations of vanadium with antidiabetics for glucose metabolism disorders
12/20/2007	US20070293556 Prophylactic or Therapeutic Agent for Diabetic Maculopathy
12/20/2007	US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007	US20070293544 Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders
12/20/2007	US20070293541 CB1 cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
12/20/2007	US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
12/20/2007	US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease
12/20/2007	US20070293509 treating eating disorders, obesity, type II diabetes, and substance abuse and/or addiction (including alcohol dependency and nicotine dependency); 6-(4-chloro-phenyl)-5-[methyl-(3-methyl-butyl)-amino]-pyrazine-2-carboxylic acid ((R)-2-cyclopropyl-2-hydroxy-propyl)-amide
12/20/2007	US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007	US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007	US20070293484 Thiophene Heteroaryl Amines
12/20/2007	US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound
12/20/2007	US20070293439 Methods and Compositions for Treating Hyperglycemic, Hyperlipidemic, or Hyperinsulinemic Disorders
12/20/2007	US20070293431 Method for improving neurotransmission failure using a novel agent
12/20/2007	US20070293430 Mutein of human FGF-21 containing an engineered disulfide where cysteine replaces leucine 118 and alanine 134, alanine for serine 167; reduced deamidation and capacity of O-glycosylation compared to wild-type human FGF-21; antidiabetic agents, type 2 diabetes; obesity; metabolic syndrome
12/20/2007	US20070293426 Methods for improving islet signaling in diabetes mellitus and for its prevention
12/20/2007	US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007	US20070292542 Flaxseeds for Body Weight Management
12/20/2007	US20070292520 Pulmonary Insulin Crystals
12/20/2007	US20070292502 Chitosan-Embedded or Encapsulated Capsule
12/20/2007	US20070292461 Oleaginous pharmaceutical and cosmetic foam
12/20/2007	US20070292440 CD154 blockade therapy for pancreatic islet tissue transplantation
12/20/2007	US20070292434 Blocking tetramerization of leptin receptor with anti-fibronectin III domain antibody, inhibiting leptin induced signalling; binding of a compound to non-leptin-binding domains of extracellular part of leptin receptor can block leptin-induced signaling without blocking leptin binding; weight modulation
12/20/2007	US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/20/2007	US20070292409 Identifying modulators of G protein-coupled receptor kinase 2 (GRK2); treatment and prevention of type 2 diabetes mellitus and insulin resistance in humans
12/20/2007	US20070292385 Phospholipase Inhibitors Localized in the Gastrointestinal Lumen
12/20/2007	DE102006027790A1 Typ-2-Diabetes Kombinations-Wafer Type 2 diabetes combination wafer
12/19/2007	EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use
12/19/2007	EP1867343A2 Novel compounds
12/19/2007	EP1867331A1 Triazole derivative and the use thereof
12/19/2007	EP1867330A1 Method of improving the storage stability of substance
12/19/2007	EP1866412A2 Ghrelin binding nucleic acids
12/19/2007	EP1866289A1 Pyrimidine carboxylic acid derivatives and use thereof
12/19/2007	EP1866286A1 Pyridine derivatives useful as inhibitors of pkc-theta
12/19/2007	EP1866285A1 1-sulfonyl-piperdine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus
12/19/2007	EP1866280A1 Acyl hydrazides as kinase inhibitors, in particular for sgk
12/19/2007	EP1865954A2 Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer
12/19/2007	EP1865949A2 Modulators of atp-binding cassette transporters
12/19/2007	EP1865945A1 Combination therapy for endothelial dysfunction, angina and diabetes

1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 1298